YASUHIRO NAIKI, MD,PhD (he/him/his)

Chief
Natl Center for Child Health & Dev
Setagaya, Tokyo, Japan

Disclosure information not submitted.

Presentation(s):

• SUN-182 - Minimally Invasive and Sustained Therapy using AAV Vectors Containing Hydroxylase Genes Combined with Coenzymes for a Mouse Model of Congenital Adrenal Hyperplasia

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF22-03 - Minimally Invasive and Sustained Therapy using AAV Vectors Containing Hydroxylase Genes Combined with Coenzymes for a Mouse Model of Congenital Adrenal Hyperplasia

  Sunday, June 14, 2026
  9:40 AM - 9:45 AM CT